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a b s t r a c t
MicroRNAs (miRNAs) belonging to the evolutionary conserved miR-302 family play important functions
in Embryonic Stem Cells (ESCs). The expression of some members, such as the human miR-302 and
mouse miR-290 clusters, is regulated by ESC core transcription factors. However, whether miRNAs act
downstream of signaling pathways involved in human ESC pluripotency remains unknown. The
maintenance of pluripotency in hESCs is under the control of the TGFβ pathway. Here, we show that
inhibition of the Activin/Nodal branch of this pathway affects the expression of a subset of miRNAs in
hESCs. Among them, we found miR-373, a member of the miR-302 family. Proper levels of miR-373 are
crucial for the maintenance of hESC pluripotency, since its overexpression leads to differentiation
towards the mesendodermal lineage. Among miR-373 predicted targets, involved in TGFβ signaling, we
validated the Nodal inhibitor Lefty. Our work suggests a crucial role for the interplay between miRNAs
and signaling pathways in ESCs.
& 2014 Elsevier Inc. All rights reserved.
Introduction
In human Embryonic Stem Cells (hESCs), the Activin/Nodal
branch of the TGFβ pathway is both necessary and sufﬁcient to
sustain pluripotency (Pera and Tam, 2010; Warmﬂash et al., 2012),
since hESCs treated with Smad2/3 inhibitors exit from pluripo-
tency and engage in differentiation (James et al., 2005; Smith et al.,
2008). Components of the hESC core transcriptional regulatory
circuitry (Boyer et al., 2005), such as Nanog, are among the genes
that are activated by Smad2/3 (Vallier et al., 2009; Singh et al.,
2012). However, the full repertoire of Smad2/3 targets remains
largely unexplored.
microRNAs (miRNAs) have lately emerged as important regu-
lators in ESCs (Martinez and Gregory, 2010), where members of
the conserved miR-302 family represent the vast majority of the
total number of miRNAs (Marson et al., 2008; Rosa and Brivanlou,
2009). We previously showed that in hESCs miR-302 both controls
mesendodermal fate speciﬁcation by targeting Lefty (Rosa et al.,
2009) and regulates their exit from pluripotency and neuroecto-
demal speciﬁcation by targeting NR2F2 (Rosa and Brivanlou, 2011).
Despite the well-established role of miRNAs in hESCs, their link to
signaling pathways remains largely elusive. In particular, whether
hESC miRNAs are downstream targets of the Activin/Nodal branch
is currently unknown.
Here, among nine miRNAs that respond to perturbations of
TGFβ signaling in hESCs, we focus on miR-373/373n, a miR-302
family member (Houbaviy et al., 2003; Suh et al., 2004). We ﬁnd
that miR-373/373n overexpression leads to exit from pluripotency
and differentiation of hESCs towards mesendodermal fates.
Mechanistically, we show that these effects could be mediated,
at least partially, by the repression of Lefty. Given that Lefty genes
are activated by Nodal/Activin signaling (Shen, 2007), our results
suggest that a network of positive/negative feedback loops, invol-
ving signaling pathways and miRNAs of the miR-302 family,
function cooperatively in order to maintain hESCs in a delicate
balance between pluripotency and differentiation.
Materials and methods
hESC culture and transgenesis
hESC line RUES2 was cultured as previously described (James
et al., 2006). Stable transgenic RUES2 lines were generated by
nucleofection of a plasmid encoding an optimized transposase
(Lacoste et al., 2009) together with the ePB-puro-TT-intRFP-miR-373
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piggyBac vector, containing the human mir-373 stem loop ﬂanked by
80 nucleotides on each side in the synthetic intron of the ePB-puro-TT-
intRFP vector (Arduini and Brivanlou, 2012). Single-cell derived
colonies were clonally passaged and selected with puromycin. Where
indicated, cells were induced with 1 μg/ml doxycycline (Sigma).
microRNA expression proﬁling and real-time qPCR analysis
RUES2 cells were treated with either 10 μΜ of SB431542
(Tocris Bioscience) or an equivalent volume of DMSO (Sigma)
and total RNA was extracted using Trizol (Invitrogen). miRNA
expression proﬁling was performed on a biological triplicate using
the Illumina human v2 miRNA panel, which detects 1146 human
miRNAs. We considered a signiﬁcant change in expression with
po0.01 and FDR o0.25. For miRNA Real-Time qPCR analysis,
cDNA was generated using the miScript Reverse Transcription Kit
(Qiagen) and analyzed with the miScript SYBR Green PCR kit and
Primer Assays (Qiagen). mRNA Real-Time qPCR analysis was
performed as described (Rosa and Brivanlou, 2011) with primers
listed in Table S2. Results were analyzed with the REST-MCS2
software (Pfafﬂ et al., 2002).
Immunostaining and western blot
Cells were stained with primary anti-BRA (R&D), anti-GATA6 (SC)
and anti-Sox17 (R&D), and secondary anti-goat- or anti-rabbit-
Alexa488 (Molecular Probes) antibodies. Images were acquired on
an Olympus IX71 inverted microscope and processed in LSM Viewer
or ImageJ. Cell counting was performed using Matlab.
Western blot was performed as described (Rosa and Brivanlou,
2011) with anti-phospho-SMAD2/3 (Cell Signaling), anti-SMAD2/3
(Transduction Laboratories), anti-α/β-tubulin (Cell Signaling) and
secondary HRP antibodies.
Chromatin Immunoprecipitation assay
Chromatin from RUES2 cells was immunoprecipitated with the
MAGnify Chromatin Immunoprecipitation System (Invitrogen)
with anti-SMAD2/3 (AF3797, R&D Systems) or with a control
rabbit IgG antibody. Primers for Real-Time qPCR analysis are listed
in Table S2.
Luciferase reporter Assays
HeLa cells were transfected as described (Rosa et al., 2009) with
400 ng/well of pRL-derivative, 40 ng/well of pGL3-Control vector
(Promega) and 10 nM miR-373, miR-373n mimic (Qiagen) or
negative control (AllStars Negative ct siRNA, Qiagen). Each condi-
tion was performed in triplicate. After 48 h, cells were analyzed
with the Dual-Luciferase Reporter kit (Promega).
Results
MEF-Conditioned Medium (CM) contains several ligands of the
TGFβ family that are necessary to maintain hESC pluripotency
(James et al., 2005). To identify TGFβ-regulated miRNAs, we
speciﬁcally blocked signaling through the SMAD2/3 branch of
the TGFβ pathway by treating hESCs with the small inhibitory
compound SB431542 (SB) (Inman et al., 2002) for 6, 12, and 24 h
(Fig. 1A). The effective block on SMAD2/3 was evidenced by strong
reduction of SMAD2 C-terminal phosphorylation (Fig. 1B) and
signiﬁcant downregulation of two direct Smad2/3 transcriptional
targets, Nodal and Lefty2 (Fig. 1C). Through miRNA proﬁling
analysis we found 9 miRNAs showing a signiﬁcant up- or down-
regulation at 24 h (Figs. 1D and S1 and Table S1). Out of these, we
decided to speciﬁcally focus on mir-373 and miR-373n, which
belong to a hESC-speciﬁc miRNA cluster (Suh et al., 2004). ChIP
analysis suggested that this regulation might be direct, as we
identiﬁed one SMAD2/3-bound site upstream of the miR-373
cluster (Fig. 1E and F). To test whether regulation was indeed
direct, we performed an induction experiment in absence of new
protein synthesis. As MEF-CM contains ligands of the TGFβ family
(Besser, 2004), we ﬁrst blocked the pathway by SB and then
induced the signaling by ActivinA in presence of the protein
synthesis inhibitor cycloheximide (CHX) (Fig. 1G). Regardless of
the presence of CHX we observed an increase of miR-373 up to its
levels in CM, demonstrating direct regulation (Fig. 1H). Activation
of the Nodal/Activin signaling in non MEF-CM did not increase the
levels of miR-373 (Fig. S2), suggesting that other signaling cues
contribute to miR-373 activation under pluripotency conditions.
Taken together, our results suggest that the SMAD2/3 branch of
the TGFβ pathway is necessary for proper levels of miR-373
expression, whereas the related miR-302 is not changed in the
same conditions (Fig. 1D, Table S1 and data not shown).
To address the role of miR-373 in hESC pluripotency, we
generated a stable and clonal transgenic hESC line in which mir-
373 ectopic expression can be induced by doxycycline treatment
(hereafter referred to as TT-mir-373 line) (Fig. 2A). Upon doxycy-
cline addition, expression of miR-373, but not miR-373n, was
increased (Fig. 2B and C). The induction efﬁciency was monitored
by RFP ﬂuorescence in live cells (Fig. 2D).
We then examined the effects of miR-373 overexpression on
hESC growth. We observed the ﬁrst signs of morphological
differentiation as early as day 3 of induction (Fig. S3), with
ﬂattening out and detaching of cells from the edges of the colonies
(Fig. S3B/Bʹ). Subsequently, most colonies lost their typical mono-
layer appearance and formed three-dimensional structures. Also, a
loss-of-contact inhibition was observed at the borders of some
colonies (Figs. 2E and S3). At the molecular level we found that
after 5 days of induction TT-mir-373 cells showed a slight reduc-
tion in the levels of pluripotency markers, whereas mesoderm and
endoderm markers were strongly upregulated (Fig. 3A). Ectoder-
mal markers do not seem to be signiﬁcantly affected at this time.
A detailed time course gene expression analysis revealed that early
mesodermal and endodermal markers Bra and Mixl1 showed a
Fig. 1. Inhibition of TGFβ signaling in hESCs results in deregulated miRNA expression. (A) RUES2 cells were cultured under pluripotency conditions in the presence of either
10 μM SB431542 (SB) or DMSO, and were harvested at the indicated time points. (B) Western blot showing that SB treatment leads to complete inhibition of C-terminal
Smad2/3 phosphorylation (P-SMAD2), without affecting total Smad2/3 protein (SMAD2) levels. α-Tubulin was used as a loading control. (C) Real-Time qPCR analysis of Nodal
and Lefty2 reveals a clear inhibition of the pathway. Data points represent average from triplicates. (D) Illumina miRNA microarray analysis of SB-treated RUES2 cells; shown
here are the miRNAs whose expression was signiﬁcantly (po0.01; FDRo0.25) up- or down-regulated after 24 h of SB treatment. (E) Schematic representation, not in scale,
of the miR-371/372/373 locus on chromosome 19. The position of two putative SMAD2/3 binding elements (SBE) (Kim et al., 2011) is depicted. The numbers are relative to
the ﬁrst nucleotide of pre-miR-371. (F) Real-Time qPCR analysis of the chromatin immunoprecipitated with the indicated antibodies. Fold change is relative to a negative
control genomic region on chromosome 4. Data points represent average from triplicates (npo0.01). (G) RUES2 cells were cultured in the presence of 10 μM SB431542 (SB)
for 24 h, then the medium was changed and the cells were cultured for additional 3 or 6 h in CM containing 50 ng/ml Activin A in absence (DMSO) or presence of 100 μg/ml
of the protein synthesis cycloheximide (CHX). Cells were harvested at the indicated time points. CM: control untreated cells. (H) Real-Time qPCR analysis of miR-373
expression. Data points represent average from triplicates. n Indicates statistically signiﬁcant difference from the SB sample (po0.01).
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very strong early upregulation at D1 and then gradually decreased;
Gsc showed a similar pattern of upregulation, yet its expression
remained strong at D7. Endodermal marker Gata6 showed a gra-
dual increase in its expression levels until it reached a 25-fold
increase at D7, and Sox17 showed very strong upregulation,
reaching a 60-fold peak at D3 and then remaining robust all
throughout the time course of analysis (Fig. 3B). This pattern of
expression is consistent with an initial transient induction of
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factors (Bra and Mixl1) known to be involved in gastrulation and
subsequently decreasing during embryogenesis, whereas tran-
scripts that also play a role during later stages (Gsc, Gata6 and
Sox17) are maintained at high levels until the end of our analysis.
At the single cell level, numerous BRA-positive cells were
present in Dox-induced TT-mir-373 colonies (Fig. 3C and Fig. S4).
After ﬁve days of miR-373 overexpression, 16% of þDox cells
were positive for BRA, when only 2% of Dox cells were positive
for this marker (Fig. 3E). GATA6 or SOX17-positive cells were
slightly differently dispersed, appearing grouped in clusters either
close to the borders or at the center of the colonies (Fig. S5).
Despite miR-373n is only minimally increased in induced cells,
compared to the strong upregulation of miR-373 (Fig. 2C), we
cannot exclude its possible contribution to the observed effects.
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(B) Real-Time miRNA qPCR analysis showing that doxycycline addition induces miR-373 expression compared to control (dox) cells. Data points are presented as relative
quantiﬁcation to the values at D0. (C) Real-Time miRNA qPCR analysis on TT-mir373 induced (þDox) cells for ﬁve days reveals that miR-373 is the predominantly expressed
miRNA from the mir-373 hairpin. Results represent fold-change of expression (at a log2 scale) compared to wild-type RUES2 cells. (D) RFP expression in live TT-mir373 cells
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Taken together, these ﬁndings show that miR-373 overexpres-
sion causes hESCs to exit from pluripotency and engage in
mesendodermal differentiation. Conversely, inhibition of miR-373
did not exert any signiﬁcant effect on pluripotency or lineage
markers (Fig. S6). This may be due to the presence in hESCs of high
levels of related miRNAs, such as miR-302 (Rosa et al., 2009).
To study the targets of miR-373, we compared 844 predicted miR-
373 targets (TargetScan (Lewis et al., 2005)) with a list of 2042 genes
that are expressed in RUES2 cells (Ismailoglu and Brivanlou, personal
communication), and found 27 to be common (Fig. S7). Among them
we found Lefty1 and Lefty2, known inhibitors of Nodal ligands
providing cue signals for the Smad2/3 branch of the TGFβ pathway.
We tested whether the two human Lefty genes are bona ﬁde targets of
miR-373 using a standard luciferase-based reporter assay in HeLa cells.
A miR-373 mimic caused repression of Lefty1- and Lefty2- WT 3ʹUTR,
which was signiﬁcantly relieved when their seeds were mutated
(Fig. 4C). miR-373n mimic had no signiﬁcant effect on either Lefty1 or
Lefty2. Accordingly, miR-373 induction in hESCs led to a signiﬁcant
reduction in the levels of both Lefty mRNAs (Fig. 4D). Taken together,
these ﬁndings suggest that miR-373, but not miR-373n, targets Lefty1
and Lefty2.
Conclusions
Even though miRNAs have been shown to participate in the
control of crucial hESC properties (Martinez and Gregory, 2010;
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Rosa and Brivanlou, 2009), little is known about their upstream
regulation. Here, we describe that some miRNAs are downstream
targets of Activin/Nodal signaling. In particular, the levels of miR-
373/373n decrease in response to Smad2/3 inhibition. Our analysis
was carried out within 24 h after the SB treatment; at this time,
direct transcriptional targets of Smad2/3, such as Nodal and Lefty
genes, are already downregulated, while indirect targets, such as
the POU5F1 gene, are not (Besser, 2004). Together with our ChIP
analysis and the evidence that Activin-mediated induction of miR-
373 is independent from protein synthesis, this suggests that miR-
373/373n is likely to be a direct target of Smad2/3, although we
cannot exclude that other signaling cues, such as the Wnt pathway
(Zhou et al., 2012), participate to the regulation of miR-373/373n
transcription.
Among miRNAs belonging to the miR-302 family in mammals,
the miR-302/367 cluster is highly conserved in mice and humans,
and is directly under the control of the core TFs Nanog, Sox2 and
Oct4 (Marson et al., 2008; Barroso-delJesus et al., 2008; Card et al.,
2008). Conversely, the human miR-371/372/373 cluster shows
poor similarity with the mouse homolog (the miR-290 cluster)
and although its regulation in the context of human cancer cells is
beginning to be studied (Zhou et al., 2012; Cairo et al., 2010;
Keklikoglou et al., 2012), to our knowledge, nothing is currently
known about its regulation in hESCs. Recent studies identiﬁed
miRNAs under the control of SMAD2/3 in mouse adult and
Embryonic Stem Cells (Redshaw et al., 2013; Yang et al., 2011).
Interestingly, the subset of miRNAs regulated by this branch of the
TGFβ pathway is different in mouse and human ESCs, with the
remarkable exception of the miR-290/miR-371/372/373 cluster,
whose regulation seems conserved.
In our previous work (Rosa et al., 2009) we have focused on the
role of miR-302 during hESC differentiation, as a model for human
embryonic development. Conversely, in the present paper we
investigated the role of miR-373 under pluripotency conditions,
before induction of differentiation. We found here that miR-302
levels are not affected by Nodal/Activin signaling inhibition, while
miR-373 is under the direct control of SMAD2/3. Therefore, despite
belonging to the same family, the two miRNAs may be not totally
redundant in hESCs. Human ESCs express prevalently miR-302/
367, while mouse ESCs (mESCs) are dominated by miR-290
members. Interestingly, the conversion from a naïve to a primed
state in mESCs correlates with a switch between the miR-302/367
and the miR-290 clusters in terms of miRNA abundance (Jouneau
et al., 2012). The primed state of mESCs corresponds to mouse
epiblast stem cells (EpiSCs), which are more similar to hESCs than
mESCs (Nichols and Smith, 2009). Accordingly, miR-373 in hESCs is
less abundant than miR-302. Our present and previous work (Rosa
et al., 2009) shows that members of both clusters converge on a
common target, Lefty. However, while upregulation of miR-302
had no consequences on undifferentiated hESCs (Rosa et al., 2009),
increased levels of miR-373 led to differentiation of hESCs towards
mesendoderm. Since the induction of mesendoderm upon miR-
373 overexpression could be only marginally rescued by a recom-
binant Lefty protein (Fig. S8), other targets probably contribute to
this biological effect.
In conclusion, a speciﬁc amount of miR-373 speciﬁed by a
discrete level of Activin/Nodal signaling must be maintained by
the cell in order to prevent differentiation. According to our model,
such speciﬁc Nodal/Activin signaling threshold activates both miR-
373 and the core TF circuitry that, in its turn, promotes transcrip-
tion of the miR-302/367 cluster. Moreover, both Nodal and Lefty
genes are positively regulated by Smad2/3, thus establishing
positive and negative feedback interactions. In this view, a critical
role played by miR-373 and miR-302 in the TGFβ pathway might
be the maintenance of a balance between agonists, such as Nodal,
and antagonists, such as Lefty.
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